- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
Impact of Drug Therapy Problems on the Management of Diabetes and Hypertension in Geriatric Patients at Sulaymaniyah City, Iraq | ||
| Al- Anbar Medical Journal | ||
| Volume 21, Issue 3, July 2025, Pages 198-205 PDF (870.01 K) | ||
| Document Type: Original articles | ||
| DOI: 10.33091/amj.2025.157370.2116 | ||
| Authors | ||
| Hozan Jaza Hama salh1; Tavga Ahmed Aziz* 2; Roshna Shawkat Aziz3; Taha Othman Mahwi4 | ||
| 1Department of Clinical Pharmacy, College of Pharmacy, University of Sulaimani, Sulaimani, Kurdistan Region, Iraq. | ||
| 2Department of Pharmacology and Toxicology, College of Pharmacy, University of Sulaimani, Sulaimani, Kurdistan Region, Iraq. | ||
| 3Department of Basic Medical Sciences, College of Medicine, University of Sulaimani, Sulaimani, Kurdistan Region, Iraq. | ||
| 4Department of Clinical Sciences, College of Medicine, University of Sulaimani, Sulaimani, Kurdistan Region, Iraq. | ||
| Abstract | ||
| Background: Drug therapy problems (DTPs) are related to many health outcomes, such as increased morbidity and mortality in geriatric diabetic patients with hypertension. Objective: To determine DTPs and the relationship between DTPs, blood pressure, and HbA1c control in elderly type 2 diabetic patients with hypertension. Material and methods: A cross-sectional study was carried out for two months at the Diabetes and Endocrine Center in Sulaimani City, Iraq. The participants were 96 elderly type 2 diabetes mellitus (T2DM) patients with hypertension who were taking at least one antidiabetic agent and at least one antihypertensive agent, and who were aged ≥ 65 years. Cipolle’s method was used to categorize DTPs. Results: Overall, 356 DTPs were observed among patients. Commonly recorded DTPs were non-compliance (41.85%) and adverse drug reactions (18.82%). A highly significant association between the number of DTPs and uncontrolled HbA1c was observed (P-value = 0.0001). However, there was no statistically significant relation between the number of DTPs and uncontrolled blood pressure (P-value = 0.059). Conclusion: The prevalence of DTPs was high among elderly patients with T2DM and hypertension, and these DTPs were associated with poor HbA1c control. It is recommended that comprehensive pharmaceutical care service be implemented for all elderly T2DM patients with hypertension. | ||
| Keywords | ||
| Drug therapy problems; Elderly; HbA1c; Hypertension; Type 2 diabetes mellitus | ||
| References | ||
|
[1] A. Singh, S. Shadangi, P. K. Gupta, and S. Rana, "Type 2 diabetes mellitus: a comprehensive review of pathophysiology, comorbidities, and emerging therapies," Comprehensive Physiology, vol. 15, no. 1, p. e70003, 2025.
[2] M. Roney et al., "Therapeutic potential inhibitor for dipeptidyl peptidase IV in diabetic type 2: in silico approaches," 3 Biotech, vol. 15, no. 1, p. 24, 2025.
[3] D. S. Abdoun, R. A. Al-Rawi, and B. Y. Abdulmajeed, "Prevalence of Dyslipidemia and Hypertension in Iraqi Adolescents with Type 1 Diabetes Mellitus," Al-Anbar Medical Journal, vol. 18, no. 2, pp. 77-81, 2022.
[4] G. Huang et al., "Association of P2X7 polymorphisms on Type 2 diabetes mellitus susceptibility and diabetic complications," PloS one, vol. 20, no. 1, p. e0318134, 2025.
[5] L. Wang et al., "Medicine Usage for Hypertension Management in Type 2 Diabetes Patients in the Rural-Urban Fringe Zone, Suzhou City, Jiangsu Province, China," Patient preference and adherence, 18:2519-2528, 2024.
[6] F.-S. Yen, J. C.-C. Wei, L.-T. Chiu, C.-C. Hsu, and C.-M. Hwu, "Diabetes, hypertension, and cardiovascular disease development," Journal of translational medicine, vol. 20, pp. 1-12, 2022.
[7] P. C.-Y. Tong et al., "Consensus statements from the diabetologists & endocrinologists alliance for the management of people with hypertension and type 2 diabetes mellitus," Journal of Clinical Medicine, vol. 12, no. 10, p. 3403, 2023.
[8] Y. Liu, J. Li, Y. Dou, and H. Ma, "Impacts of type 2 diabetes mellitus and hypertension on the incidence of cardiovascular diseases and stroke in China real-world setting: a retrospective cohort study," BMJ open, vol. 11, no. 11, p. e053698, 2021.
[9] R. Adisa and D. Osoba, "Evaluation of drug therapy problems among outpatient hypertensive and type-2-diabetic patients at a tertiary hospital, South-West Nigeria," Nigerian Journal of Pharmaceutical Research, vol. 15, no. 2, pp. 127-141, 2019.
[10] G. T. D. Gebre Teklemariam Demoz, A. B. B. Alemseged Beyene Berha, M. A. W. Minyahil Alebachew Woldu, H. Y. Helen Yifter, W. S. Workineh Shibeshi, and E. E. Ephrem Engidawork, "Drug therapy problems, medication adherence and treatment satisfaction among diabetic patients on follow-up care at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia," 14(10):1-17, 2019.
[11] A. C. Hazen et al., "Non-dispensing pharmacists’ actions and solutions of drug therapy problems among elderly polypharmacy patients in primary care," Family practice, vol. 36, no. 5, pp. 544-551, 2019.
[12] H. C. Koyra, S. B. Tuka, and E. G. Tufa, "Epidemiology and predictors of drug therapy problems among type 2 diabetic patients at Wolaita Soddo University Teaching Hospital, Southern Ethiopia," Am J Pharmacol Sci, vol. 5, no. 2, pp. 40-48, 2017.
[13] B. Kefale, G. T. Tegegne, Y. Kefale, M. Molla, A. Ewunetei, and A. Degu, "Magnitude and determinants of drug therapy problems among type 2 diabetes mellitus patients with hypertension in Ethiopia," SAGE open medicine, vol. 8, p. 2050312120954695, 2020.
[14] L. Nabila, S. Ejaz, and S. Al Madury, "Drug-related problems (DRPs) in geriatric patients with type 2 diabetes mellitus (T2DM): a review," Indonesian Journal of Pharmacology and Therapy, 3(2):91-99, 2022.
[15] H. S. Namiq, K. A. Obeid, and D. A. Mohammed, "Role of pharmaceutical care in type 2 diabetic patients in Kirkuk City," Al Mustansiriyah Journal of Pharmaceutical Sciences, vol. 20, no. 4, pp. 169-181, 2020.
[16] T. O. Mahwi and K. A. Obied, "Role of the pharmaceutical care in the management of patients with type 2 diabetes mellitus," International Journal of Pharmaceutical Sciences and Research, vol. 4, no. 4, p. 1363, 2013.
[17] A. Samaila, U. I. Ibrahim, A. A. Biambo, and B. M. Tambuwal, "Evaluation of treatment effectiveness and 10-year cardiovascular disease risk level in hypertensive outpatients," Journal of Applied Pharmaceutical Science, vol. 14, no. 7, pp. 169-174, 2024.
[18] Z. Lin et al., "Glycemic control and cardiovascular outcomes in patients with diabetes and coronary artery disease according to triglyceride-glucose index: a large-scale cohort study," Cardiovascular Diabetology, vol. 23, no. 1, p. 11, 2024.
[19] H. J. H. Salh, T. A. Hussein, and T. A. Aziz, "Highlighting the Issues associated with glaucoma medication therapy: a pharmaceutical care evaluation," Al-Rafidain Journal of Medical Sciences (ISSN 2789-3219), vol. 5, pp. 57-66, 2023.
[20] J. F. Committee, British national formulary. Pharmaceutical Press, 2012.
[21] T. Sheleme, T. Sahilu, and D. Feyissa, "Identification and resolution of drug-related problems among diabetic patients attending a referral hospital: a prospective observational study," Journal of pharmaceutical policy and practice, vol. 14, pp. 1-10, 2021.
[22] H. Zaman Huri and H. Fun Wee, "Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study," BMC endocrine disorders, vol. 13, pp. 1-12, 2013.
[23] M. Yimama, H. Jarso, and T. A. Desse, "Determinants of drug-related problems among ambulatory type 2 diabetes patients with hypertension comorbidity in Southwest Ethiopia: a prospective cross sectional study," BMC Research Notes, vol. 11, pp. 1-6, 2018.
[24] K. F. Šola, I. Mucalo, A. Brajković, I. Jukić, D. Verbanac, and S. Vladimir Knežević, "Drug therapy problems identified among older adults placed in a nursing home: the Croatian experience," Journal of International Medical Research, vol. 48, no. 6, p. 0300060520928791, 2020.
[25] B. Ogbonna, C. Ezenduka, C. Opara, and L. Ahara, "Drug therapy problems in patients with Type-2 Diabetes in a tertiary hospital in Nigeria," Int J Innov Res Dev, vol. 3, no. 1, pp. 494-502, 2014.
[26] U. Eze, C. Oparah, and F. Lawal, "Identification of Drug Therapy Problems among Elderly in-patients of a Nigerian Teaching Hospital," Nigerian Journal of Pharmaceutical Research, vol. 9, no. 1, 2011.
[27] S. Hartuti, A. Nasution, and S. Syafril, "The effect of drug-related problems on blood glucose level in the treatment of patients with type 2 diabetes mellitus," Open Access Macedonian Journal of Medical Sciences, vol. 7, no. 11, p. 1798, 2019.
[28] L. T. Alberta, R. D. Ardiana, S. H. Wuryaningsih, and R. Ambarwati, "Cross Sectional Studies: the Relationship between Medication Adherence and Blood Sugar Levels of Type 2 Diabetes Mellitus Patients," in 6th International Conference of Health Polytechnic Surabaya (ICoHPS 2023), Atlantis Press, pp. 466-476, 2023.
[29] M. Babirye, T. M. Yadesa, R. Tamukong, and P. S. Obwoya, "Prevalence and factors associated with drug therapy problems among hypertensive patients at hypertension clinic of Mbarara Regional Referral Hospital, Uganda: a| cross-sectional study," Therapeutic Advances in Cardiovascular Disease, vol. 17, p. 17539447231160319, 2023.
[30] W. APARECIDA DE SOUZA, J. C. YUGAR-TOLEDO, G. BERGSTEN-MENDES, M. SABHA, and H. MORENO, "Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension," American journal of health-system pharmacy, vol. 64, no. 18, pp. 1955-1961, 2007.
| ||
|
Statistics Article View: 507 PDF Download: 530 |
||